JP2015527975A - カルコゲニドを含む組成物および関連方法 - Google Patents

カルコゲニドを含む組成物および関連方法 Download PDF

Info

Publication number
JP2015527975A
JP2015527975A JP2015517392A JP2015517392A JP2015527975A JP 2015527975 A JP2015527975 A JP 2015527975A JP 2015517392 A JP2015517392 A JP 2015517392A JP 2015517392 A JP2015517392 A JP 2015517392A JP 2015527975 A JP2015527975 A JP 2015527975A
Authority
JP
Japan
Prior art keywords
oxygen
chalcogenide
stable composition
composition
certain embodiments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015517392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015527975A5 (enExample
Inventor
マーク ビー． ロス，
マーク ビー． ロス，
マイケル エル． モリソン，
マイケル エル． モリソン，
アキコ イワタ，
アキコ イワタ，
Original Assignee
フレッド ハッチンソン キャンサー リサーチ センター
フレッド ハッチンソン キャンサー リサーチ センター
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フレッド ハッチンソン キャンサー リサーチ センター, フレッド ハッチンソン キャンサー リサーチ センター filed Critical フレッド ハッチンソン キャンサー リサーチ センター
Publication of JP2015527975A publication Critical patent/JP2015527975A/ja
Publication of JP2015527975A5 publication Critical patent/JP2015527975A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • C01B17/24—Preparation by reduction
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • C01B17/32—Hydrosulfides of sodium or potassium
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00—Selenium; Tellurium; Compounds thereof
    • C01B19/007—Tellurides or selenides of metals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00—Selenium; Tellurium; Compounds thereof
    • C01B19/04—Binary compounds including binary selenium-tellurium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/08—Tubes; Storage means specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
JP2015517392A 2012-06-13 2013-06-12 カルコゲニドを含む組成物および関連方法 Pending JP2015527975A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261659311P 2012-06-13 2012-06-13
US61/659,311 2012-06-13
US201361798043P 2013-03-15 2013-03-15
US61/798,043 2013-03-15
PCT/US2013/045395 WO2013188528A1 (en) 2012-06-13 2013-06-12 Compositions comprising chalcogenides and related methods

Publications (2)

Publication Number Publication Date
JP2015527975A true JP2015527975A (ja) 2015-09-24
JP2015527975A5 JP2015527975A5 (enExample) 2016-05-26

Family

ID=49758688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517392A Pending JP2015527975A (ja) 2012-06-13 2013-06-12 カルコゲニドを含む組成物および関連方法

Country Status (13)

Country Link
US (1) US20150290240A1 (enExample)
EP (1) EP2861718A4 (enExample)
JP (1) JP2015527975A (enExample)
KR (1) KR20150021509A (enExample)
CN (1) CN104471058A (enExample)
AU (1) AU2013274325A1 (enExample)
BR (1) BR112014030992A2 (enExample)
CA (1) CA2875212A1 (enExample)
HK (1) HK1209782A1 (enExample)
IN (1) IN2014MN02391A (enExample)
MX (1) MX2014014524A (enExample)
RU (1) RU2015100257A (enExample)
WO (1) WO2013188528A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX386702B (es) * 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
CN109650353A (zh) * 2019-01-14 2019-04-19 成都中建材光电材料有限公司 一种高纯二硫化硒的制备方法
US20230256003A1 (en) * 2020-06-25 2023-08-17 Industry-University Cooperation Foundation Hanyang University Erica Campus Pharmaceutical composition for preventing or treating sepsis containing functionalized transition metal dichalcogenide
CN114471430B (zh) * 2022-02-07 2024-01-02 天津大学 一种连续生产碱金属硫化物的装置及其合成方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51112697A (en) * 1975-03-04 1976-10-05 Smith & Nephew Pharma Liquid package
JP2000506594A (ja) * 1995-09-12 2000-05-30 パルプ アンド ペーパー リサーチ インスチチュート オブ カナダ 緑液およびスメルト溶液中の硫化ナトリウムおよび硫化度の測定
JP2002315595A (ja) * 2001-04-04 2002-10-29 Consortium Elektrochem Ind Gmbh 非タンパク質ｌ−アミノ酸の製造方法
JP2007275889A (ja) * 2007-04-27 2007-10-25 Masahiro Izutsu リグノセルロース系バイオマスの利用方法
JP2007537296A (ja) * 2004-05-14 2007-12-20 アボット・ラボラトリーズ 治療薬としてのキナーゼ阻害薬
JP2008208063A (ja) * 2007-02-26 2008-09-11 Institute Of Physical & Chemical Research ４，５−ジメチル−［１，３］ジセレノール−２−セロンの新規製造方法
JP2010505879A (ja) * 2006-10-05 2010-02-25 イカリア， インコーポレイテッド 液体カルコゲナイド組成物ならびにそれを製造および使用する方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208336A (en) * 1990-10-19 1993-05-04 Sterling Drug Inc. Selenomerocyanines and processes for preparation and methods of use and compositions thereof
PE20001435A1 (es) * 1998-11-16 2000-12-14 Paques Bio Syst Bv Proceso para la produccion de sulfuro de hidrogeno a partir de azufre en su condicion elemental y uso del mismo en la recuperacion de metales pesados
EP1479725B1 (en) * 2002-02-26 2014-05-14 Kuraray Co., Ltd. Resin composition and multi-layer structures
WO2007124447A2 (en) * 2006-04-20 2007-11-01 Fred Hutchinson Cancer Research Center Use of chalcogenides for treating shock and other adverse conditions
RU2015109165A (ru) * 2008-03-06 2015-11-10 Анакор Фармасьютикалз, Инк. Борсодержащие малые молекулы в качестве противовоспалительных агентов

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51112697A (en) * 1975-03-04 1976-10-05 Smith & Nephew Pharma Liquid package
JP2000506594A (ja) * 1995-09-12 2000-05-30 パルプ アンド ペーパー リサーチ インスチチュート オブ カナダ 緑液およびスメルト溶液中の硫化ナトリウムおよび硫化度の測定
JP2002315595A (ja) * 2001-04-04 2002-10-29 Consortium Elektrochem Ind Gmbh 非タンパク質ｌ−アミノ酸の製造方法
JP2007537296A (ja) * 2004-05-14 2007-12-20 アボット・ラボラトリーズ 治療薬としてのキナーゼ阻害薬
JP2010505879A (ja) * 2006-10-05 2010-02-25 イカリア， インコーポレイテッド 液体カルコゲナイド組成物ならびにそれを製造および使用する方法
JP2008208063A (ja) * 2007-02-26 2008-09-11 Institute Of Physical & Chemical Research ４，５−ジメチル−［１，３］ジセレノール−２−セロンの新規製造方法
JP2007275889A (ja) * 2007-04-27 2007-10-25 Masahiro Izutsu リグノセルロース系バイオマスの利用方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
INT. J. APPL. RADAT. ISOT., 1975, VOL.26, NO.11, PP.695-697, JPN6017004553, ISSN: 0003499806 *
J. LABELLED COMP. RADIOPHARM., 1983, VOL.20, NO.4. PP.487-494, JPN6017004554, ISSN: 0003499807 *
TETRAHEDRON LETT., 2002, VOL.43, VOL.16, PP.3083-3086, JPN6017004552, ISSN: 0003499805 *

Also Published As

Publication number Publication date
US20150290240A1 (en) 2015-10-15
WO2013188528A1 (en) 2013-12-19
IN2014MN02391A (enExample) 2015-08-21
AU2013274325A1 (en) 2014-12-11
MX2014014524A (es) 2015-02-24
EP2861718A4 (en) 2016-03-23
RU2015100257A (ru) 2016-08-10
CN104471058A (zh) 2015-03-25
CA2875212A1 (en) 2013-12-19
BR112014030992A2 (pt) 2017-06-27
KR20150021509A (ko) 2015-03-02
EP2861718A1 (en) 2015-04-22
HK1209782A1 (en) 2016-04-08

Similar Documents

Publication Publication Date Title
KR101538727B1 (ko) 액체 칼코게나이드 조성물 및 이의 제조방법과 사용방법
US9474746B2 (en) Methods for stabilizing oxidatively unstable compositions
CN106102836A (zh) 心脏病发作和缺血性损伤的卤素治疗
JP2015527975A (ja) カルコゲニドを含む組成物および関連方法
US20200188478A1 (en) Pre-mixed, ready to use vancomycin compositions
US20120208887A1 (en) Stable, liquid, ready-to-use ketoprofen formulations
CZ20022654A3 (cs) Farmaceutická kompozice, obsahující Pemetrexed společně s monothioglycerolem, L-cysteinem nebo kyselinou thioglykolovou
JP2024531479A (ja) 凍結乾燥製剤溶液および凍結乾燥製剤、ならびにそれらの方法および使用
US12005069B2 (en) Bortezomib compositions
KR20250160163A (ko) 용액, 동결건조 제형, 동결건조 제형 단위 패키지, 주사제, 및 주사제 제조 방법
US12383497B2 (en) Ready-to-use phenylephrine formulations and products
HK40119827A (zh) 稳定的普那布林制剂及其制备与使用方法
WO2024214110A1 (en) A safe pharmaceutical composition of hydrocortisone
EP4308082A1 (en) Stable formulations of indocyanine green

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160325

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170216

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20171102